Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Taro Pharmaceutical Industries Ltd. (TARO)

82.31   -0.59 (-0.71%) 07-15 16:02
Open: 83.02 Pre. Close: 82.9
High: 83.39 Low: 81.58
Volume: 22,860 Market Cap: 3172M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 83.626 - 84.089 84.089 - 84.466
Low: 80.142 - 80.8 80.8 - 81.335
Close: 81.339 - 82.318 82.318 - 83.114

Technical analysis

as of: 2019-07-15 4:45:40 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 102.96     One year: 107.70
Support: Support1: 81.58    Support2: 67.87
Resistance: Resistance1: 88.15    Resistance2: 92.21
Pivot: 84.25
Moving Average: MA(5): 82.91     MA(20): 85.11
MA(100): 99.10     MA(250): 99.53
MACD: MACD(12,26): -2.66     Signal(9): -2.86
Stochastic oscillator: %K(14,3): 11.11     %D(3): 11.41
RSI: RSI(14): 29.29
52-week: High: 117.45  Low: 76.93  Change(%): -28.2
Average Vol(K): 3-Month: 6989  10-Days: 5107

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TARO has closed above bottom band by 8.4%. Bollinger Bands are 43.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to TARO's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 10 Jul 2019 19:06:59 Z
Taro Pharmaceutical Industries Becomes Oversold (TARO)

Tue, 25 Jun 2019 15:14:13 Z
Why Taro Pharmaceutical (TARO) Could Be Positioned for a Slump

Fri, 21 Jun 2019 08:28:01 Z
Validea Benjamin Graham Strategy Daily Upgrade Report - 6/21/2019

Thu, 23 May 2019 20:27:02 Z
Health Care Sector Update for 05/23/2019: TARO,IOVA,NVCN,XBIT

Thu, 23 May 2019 02:06:41 Z
Taro Pharmaceutical (TARO) Misses Q4 Earnings and Revenue Estimates

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 39.02
Shares Float (M) 9.06
% Held by Insiders 75.60
% Held by Institutions 10.97
Shares Short (K) 295
Shares Short P. Month (K)

Stock Financials

EPS 7.230
EPS Est. Current Year 9.490
EPS Est. Next Year 7.990
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 49.440
PEG Ratio -0.73
Profit Margin 42.06
Operating Margin 43.67
Return on Assets (ttm) 8.0
Return on Equity (ttm) 13.7
Qtrly Rev. Growth 2.7
Gross Profit (p.s.) 11.423
Sales Per Share
EBITDA (p.s.) 7.973
Qtrly Earnings Growth -32.30
Operating Cash Flow (M) 323.71
Levered Free Cash Flow (M) 212.27

Stock Valuations

P/E 11.38
P/E Growth Ratio -0.01
P/BV 1.66
P/S 186946224.00
P/CF 9.92

Dividends & Splits

Dividend Yield
Dividend Pay Date 2018-12-28
Ex-Dividend Date 2018-12-10
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.